首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING GPCR19 AGONIST AS AN ACTIVE INGREDIENT

COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING GPCR19 AGONIST AS AN ACTIVE INGREDIENT

机译:预防或治疗包含GPCR19激动剂的原子性皮肤病的成分

摘要

The present invention relates to a pharmaceutical composition, an oral preparation, an injection preparation, and a drug for external use and a cosmetic composition for preventing or treating atopic dermatitis, which contain GPCR19 agonist or sodium taurodeoxycholate and a derivative of the same as an active ingredient, which have an excellent effect for treating and reducing atopic dermatitis even compared with an existing steroid ointment and immunosuppression ointment, directly reduces the amount of serum immune globulin lgE which is a main factor of symptoms of atopic dermatitis, increases TH1 cytokine which relieves symptoms of atopic dermatitis, reduces TH2 cytokine making symptoms of atopic dermatitis worse, and reduces permeation of mast cells, eosinocyte, and neutrophil in hypodermal cells, thereby applicable as a medicinal composition for preventing and treating atopic dermatitis.
机译:本发明涉及含有GPCR19激动剂或牛磺脱氧胆酸钠及其衍生物作为活性成分的药物组合物,口服制剂,注射剂,外用药物以及用于预防或治疗特应性皮炎的化妆品组合物。成分,与现有的类固醇软膏和免疫抑制软膏相比,对特应性皮炎的治疗和减轻效果极佳,可直接降低作为特应性皮炎症状的主要因素的血清免疫球蛋白lgE的量,增加TH1细胞因子以缓解症状特应性皮炎的治疗,减少TH2细胞因子,使特应性皮炎的症状加重,并减少肥大细胞,嗜曙红细胞和中性粒细胞在表皮细胞中的渗透,因此可用作预防和治疗特应性皮炎的药物组合物。

著录项

  • 公开/公告号KR20150024805A

    专利类型

  • 公开/公告日2015-03-09

    原文格式PDF

  • 申请/专利权人 SNU R&DB FOUNDATION;

    申请/专利号KR20140125691

  • 发明设计人 SEUNG YONG SEONG;KIM YOUN HEE;

    申请日2014-09-22

  • 分类号A61K31/56;A61K31/255;A61K8/63;A61K9/20;A61P17;A61Q19;

  • 国家 KR

  • 入库时间 2022-08-21 15:00:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号